BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an extravascular ICD system to treat tachycardia that may cause sudden cardiac arrest. Placing ...
SALT LAKE CITY--(BUSINESS WIRE)-- Healthcare reform, new compliance regulations, and the move to outcomes-based payment are putting pressure on clinical documentation and coding processes at hospitals ...
Medtronic's EV ICD System Proves Effective in Cardiac Arrhythmia Management: Long-term Study Results
Medtronic plc MDT announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart rhythms ...
Leap I-10 provides a foundation of analytics to help hospitals evaluate the potential impact of the ICD-10 conversion process across departments, applications, processes and workflows. The solution ...
Abbott announced that the FDA approved its next-generation Bluetooth-capable implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator devices. The devices (Gallant, ...
In partnership with data partner Plant A, Newsweek ranks America's Greatest Companies, where health care-related companies shine.
The AHA is providing member hospitals with an executive briefing book to help them prepare for the 2013 transition to the 10th edition of the International Classification of Diseases clinical coding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback